...
首页> 外文期刊>British Journal of Cancer >Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932women
【24h】

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932women

机译:人类乳头瘤病毒测试在初筛中发现高级别宫颈病变的研究:7932名女性的研究

获取原文

摘要

High-risk human papillomaviruses (HR-HPV) are the necessary cause of cervical carcinomas. To determine whether HPR-HPV DNA detection in primary routine screening could represent a sensitive and reliable technique for the detection of high-grade squamous intraepithelial lesions (HGSIL), laboratory analysis using 2 cytologic techniques (conventional and liquid-based), HPV testing with Hybrid Capture II assay (HC-II), followed by colposcopic examination of women with abnormal cervical finding and/or persistent HR-HPV infection, was conducted in 7932 women who had routine cervical examination. The sensitivity of HPV testing for detecting a histologically proven HGSIL was 100%, higher than that of conventional (68.1%) and liquid-based (87.8%) cytology. The low specificities of 85.6% and 87.3% of HPV testing slightly increased to 88.4% and 90.1% if HPV testing was reserved for woman >30 years old. The quantitative approach provided by the HC-II assay for the assessment of the viral load was not reliable for predicting HGSIL in normal smears. HR-HPV testing could be proposed in primary screening in association with cytology. With conventional cytology it significantly improves the detection of HGSIL. With the use of the same cervical scrape for HPV testing and liquid-based cytology, HR-HPV testing would allow to select positive samples treated in a second time for cytology which gives a good specificity. ? 2001 Cancer Research Campaign http://www.bjcancer.com
机译:高危人类乳头瘤病毒(HR-HPV)是宫颈癌的必要原因。为了确定初级常规筛查中的HPR-HPV DNA检测是否可以代表检测高级别鳞状上皮内病变(HGSIL)的灵敏可靠的技术,使用2种细胞学技术(常规和液基)的实验室分析,HPV检测以及在常规宫颈检查的7932名妇女中,进行了Hybrid Capture II分析(HC-II),然后进行阴道镜检查,发现宫颈异常和/或持续性HR-HPV感染。 HPV检测对组织学证实的HGSIL的敏感性为100%,高于传统的细胞学(68.1%)和液基细胞学(87.8%)。如果HPV检测仅用于30岁以上的女性,则HPV检测的低特异性85.6%和87.3%会稍微增加到88.4%和90.1%。 HC-II分析提供的用于评估病毒载量的定量方法对于预测正常涂片中的HGSIL不可靠。 HR-HPV检测可与细胞学结合用于初筛。使用常规细胞学,可以显着改善HGSIL的检测。通过使用相同的宫颈刮片进行HPV检测和基于液体的细胞学检查,HR-HPV检测将允许选择第二次处理的阳性样品进行细胞学检查,从而获得良好的特异性。 ? 2001年癌症研究运动http://www.bjcancer.com

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号